April 2024
1. ROSENBROCK J, Kaul H, Oertel M, Celik E, et al
   Involved-site radiotherapy is equally effective and less toxic than Involved-field radiotherapy in patients receiving combined modality treatment for early-stage unfavorable Hodgkin lymphoma - an analysis of the randomized phase III HD17 trial of the
   Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00514.
   

   >> Share

   
   
2. PARIKH RR, Milgrom SA, Campbell BA
   Pushing the CART to the Finish Line: Integrating Radiation Therapy Into Chimeric Antigen Receptor T-Cell Therapy Programs to Improve Outcomes for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
   Int J Radiat Oncol Biol Phys. 2024;118:1152-1158.
   

   >> Share

   
   November 2023
3. NIU S, Li Y, Shao H, Hu J, et al
   Phase II clinical trial of simultaneous-boost IMRT with three dose gradients in patients with stage I-II nasal type natural killer/T-cell lymphoma: long-term outcomes of survival and quality of life: Simultaneous-boost intensity-modulated radiotherapy
   Int J Radiat Oncol Biol Phys. 2023 Nov 6:S0360-3016(23)07944.
   

   >> Share

   
   September 2023
4. ELSAYAD K, Weishaupt C, Moustakis C, Danzer MF, et al
   Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sezary Syndrome.
   Int J Radiat Oncol Biol Phys. 2023;117:164-170.
   

   >> Share

   
   May 2023
5. ALEMAN BMP, Ricardi U, van der Maazen RWM, Meijnders P, et al
   A quality control study on involved node radiotherapy in the EORTC/LYSA/FIL H10 Trial on stages I/II Hodgkin lymphoma; lessons learned.
   Int J Radiat Oncol Biol Phys. 2023 May 11:S0360-3016(23)00455.
   

   >> Share

   
   April 2023
6. VEGA RBM, Harker-Murray PD, Forlenza CJ, Cole P, et al
   Radiotherapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group.
   Int J Radiat Oncol Biol Phys. 2023 Apr 26:S0360-3016(23)00381.
   

   >> Share

   
   March 2023
7. HOPPE BS, McCarten KM, Pei Q, Kessel S, et al
   Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using PET Response-Adapted Radiotherapy.
   Int J Radiat Oncol Biol Phys. 2023 Mar 1:S0360-3016(23)00164.
   

   >> Share

   
   February 2023
8. LEVIS M, Campbell BA, Matrone F, Grapulin L, et al
   Peri-transplant radiotherapy in refractory or relapsed Hodgkin lymphoma patients undergoing autologous stem cell transplant: long term results of a retrospective study of the Fondazione Italiana Linfomi (FIL).
   Int J Radiat Oncol Biol Phys. 2023 Feb 21:S0360-3016(23)00165.
   

   >> Share

   
   December 2022
9. SAIFI O, Breen WG, Lester SC, Rule WG, et al
   Don't put the CART before the horse: The role of radiation therapy in peri-CAR T-cell therapy for aggressive B-cell non-Hodgkin lymphoma.
   Int J Radiat Oncol Biol Phys. 2022 Dec 20:S0360-3016(22)03637.
   

   >> Share

   
   July 2022
10. CHOPRA S, Kalra B, Mulani J, Jain J, et al
    Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 15. pii: S0360-3016(22)00722.
    

    >> Share

    
    April 2022
11. CHAI Y, Chen B, Qi F, Fang H, et al
    First-line chemoradiation with or without chidamide (tucidinostat) in patients with early stage intermediate- and high-risk early-stage extranodal nasal-type natural killer/T-cell lymphoma: a randomized phase 2 study in China.
    Int J Radiat Oncol Biol Phys. 2022 Apr 19. pii: S0360-3016(22)00312.
    

    >> Share

    
    February 2022
12. LADBURY C, Kambhampati S, Othman T, Hao C, et al
    Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post Autologous Stem Cell Transplant.
    Int J Radiat Oncol Biol Phys. 2022 Feb 14. pii: S0360-3016(22)00161.
    

    >> Share

    
    January 2022
13. SHER DJ
    Fifty Shades of GyE: Interpreting the Cost-Effectiveness of Proton Beam Therapy for Mediastinal Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2022;112:167-168.
    

    >> Share

    
    December 2021
14. YEOH KW, Yong FY
    Combined Modality Therapy in Extranodal NK/T Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1103-1105.
    

    >> Share

    
    
15. THOMAS HR, Yom SS
    Right on the Nose: A Case of Locally Invasive Extranodal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1101-1102.
    

    >> Share

    
    
16. WU SY, Pinnix CC
    Chemoradiation to Improve Local Control, and Thereby Overall Survival for Limited Stage Nasal NKTCL.
    Int J Radiat Oncol Biol Phys. 2021;111:1105-1106.
    

    >> Share

    
    
17. YANG Y
    Short-Course Induction Chemotherapy Followed by Radiotherapy is the Effective Strategy for Intermediate-Risk/High-Risk Early-Stage ENKTCL.
    Int J Radiat Oncol Biol Phys. 2021;111:1103.
    

    >> Share

    
    
18. FIGURA NB, Robinson TJ, Sim AJ, Wang X, et al
    Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:1145-1154.
    

    >> Share

    
    November 2021
19. MILGROM SA, Bakst RL, Campbell BA
    Clinical Outcomes Confirm Conjecture: Modern Radiation Therapy Reduces the Risk of Late Toxicity in Survivors of Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:841-850.
    

    >> Share

    
    
20. PARIKH RR, Kelly KM, Hodgson DC, Hoppe BS, et al
    Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (XXXX): A Report from the Children's Oncology Group.
    Int J Radiat Oncol Biol Phys. 2021 Nov 9. pii: S0360-3016(21)03075.
    

    >> Share

    
    
21. NTENTAS G, Dedeckova K, Andrlik M, Aznar MC, et al
    Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
    Int J Radiat Oncol Biol Phys. 2021 Nov 8. pii: S0360-3016(21)03074.
    

    >> Share

    
    
22. PLASTARAS JP, Svoboda J
    PET/CT Responses in Primary Mediastinal Large B-Cell Lymphoma: What's Negative?
    Int J Radiat Oncol Biol Phys. 2021;111:595-596.
    

    >> Share

    
    
23. KRAUS R, Tao R
    To Radiate or Not to Radiate? Implications of PET Biomarkers in Primary Mediastinal B-cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:594.
    

    >> Share

    
    
24. ANDERSON G, Shinde A
    Primary Mediastinal B-Cell Lymphoma: The Role of Consolidative Radiation for a "Terrible" Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:592-593.
    

    >> Share

    
    
25. PATEL AM, Ali O, Kainthla R, Rizvi S, et al
    Primary CNS Lymphoma: Comparison of Outcomes and the Use of Radiation Therapy in Patients Treated at a Public Safety Net Hospital vs. a Tertiary Academic Center.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
26. VASILIADOU I, Mikhaeel G, Brady JL, Poetter V, et al
    Factors Affecting Outcome of Bridging Radiotherapy (RT) Before CAR-T for High Grade Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
27. GRIFFITH T, Parsons MW, Tward JD, Tao R, et al
    Risk of Secondary Breast Cancer in Female Non-Hodgkin Lymphoma Survivors: 40 Years of Follow-Up Assessed by Treatment Modality.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
28. WRIGHT CM, Baron J, Lee DY, Carpenter M, et al
    Disease Outcomes Following Low-Dose Radiotherapy vs. Moderate-Dose Radiotherapy for Orbital Low Grade Non-Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
29. KIM JK, Zhang JY, Wang W, McCarthy A, et al
    A Dosimetric Comparison of IMRT and 3D-CRT Using Deep Inspiratory Breath Hold (DIBH) and Free-Breathing (FB) Techniques in Gastric Mucosa Lymphoid Tissue Lymphoma (MALT).
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
30. RAVELLA R, Zhang-Velten ER, Awan F, Rizvi S, et al
    Analysis of Patterns of Failure and the Role of Bridging Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Treated with CAR T-Cell Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
31. MANJUNATH SH, Larose MI, Carpenter M, Svoboda J, et al
    Radiation Therapy (RT)-Based Salvage Therapy for Classical Hodgkin Lymphoma (cHL).
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
32. CHAMBERLIN HC, Astley S, Cowan R, Hague C, et al
    Breast Dose in Young Women Treated for Hodgkin Lymphoma Between 2007 and 2018: A Single Institutional Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
33. ZHANG YT, Li N, Wang JJ, Li YM, et al
    Association of B Symptoms With Plasma EBV-DNA Copy Number and Cytokine Profiles in Patients With Nasal Type Extranodal Natural Killer/T-Cell Lymphoma (ENKTL): A Mechanism and Prognostic Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
34. KINSLOW CJ, Krishnamurthy PB, Sanchez GI, Wang TJC, et al
    Risk of Anaplastic Large Cell Lymphoma After Post-Mastectomy Implant-Reconstruction for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
35. ZHENG X, He X, Yang Y, Qi SN, et al
    Improved Overall Survival Associated With Decreased Distant Metastasis Following Asparaginase-Based Chemotherapy and Radiotherapy for Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
36. MILLIGAN MG, Chukwueke UN, Fisher DC, Ng AK, et al
    Stereotactic Radiation Therapy With Concurrent Immune Checkpoint Inhibitor Therapy in Patients With Relapsed or Refractory Central Nervous System Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
37. KIM JS, Kim IH, Byun JM, Chang JH, et al
    Population-Based Study on the Association Between Autoimmune Disease and Lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
38. SAKTHIVEL G, Chowdhry AK, Milano MT
    Second Primary Urinary Cancer in Hodgkin Lymphoma Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
39. ROCK CB, Parsons MW, Chipman J, Shah H, et al
    Secondary Malignancies in Diffuse Large B-cell Lymphoma Survivors With 40 Years of Follow-Up: Influence of Chemotherapy and Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
40. MILGROM SA, Kim J, Hoppe BS, Pei Q, et al
    PET-Based Quantification of Baseline Metabolic Tumor Burden Improves Risk Stratification in High-Risk Hodgkin Lymphoma: A Children's Oncology Group Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
41. COUTU BG, Lawrence E, Bociek G, Armitage J, et al
    Consolidative Radiotherapy Remains a Key Player in the Salvage Management of Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
42. SAIFI O, Breen W, Lester SC, Rule WG, et al
    Radiation Therapy as Bridging Treatment to CAR T Cell Therapy in Non-Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
43. BREEN W, Hathcock M, Young JR, Stish BJ, et al
    Metabolic Kinetics of Non-Hodgkin Lymphoma Prior to CAR-T Infusion: Prognostic Factors and Risk Stratification.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
44. KUHNL A, Mikhaeel G, Kirkwood AA, Menne TF, et al
    Radiotherapy Bridging in Patients With R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
45. URBAN R, Chow R, Pickles T, Chan M, et al
    The Impact of Surveillance Imaging After Curative Intent Radiotherapy for Limited Stage Follicular Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
46. MACMANUS MP, Roos DE, O'Brien P, Anne C, et al
    Prospective Phase II Trial of Radiation Therapy in Localized Non-Gastric Marginal Zone Lymphoma With Evaluation of Autoimmunity and Helicobacter Pylori Status.
    Int J Radiat Oncol Biol Phys. 2021;111.
    

    >> Share

    
    
47. KHAN MK, Mourad WF
    Biopsy, as Deauville May Deceive.
    Int J Radiat Oncol Biol Phys. 2021;111:594-595.
    

    >> Share

    
    August 2021
48. HALL MD, Terezakis SA, Lucas JT Jr, Gallop-Evans E, et al
    Radiotherapy across pediatric Hodgkin lymphoma research group protocols: a report from the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) Group.
    Int J Radiat Oncol Biol Phys. 2021 Aug 11. pii: S0360-3016(21)02629.
    

    >> Share

    
    
49. BAUES C, Goergen H, Fuchs M, Rosenbrock DJ, et al
    Involved-Field Radiotherapy prevents recurrences in the early stages of Hodgkin's lymphoma in PET-negative patients after ABVD Chemotherapy Relapse Analysis of GHSG Phase III HD16 Trial.
    Int J Radiat Oncol Biol Phys. 2021 Aug 10. pii: S0360-3016(21)02599.
    

    >> Share

    
    
50. VEGA RBM, Mohammadi H, Patel SH, Md ALH, et al
    Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma.
    Int J Radiat Oncol Biol Phys. 2021 Aug 1. pii: S0360-3016(21)02624.
    

    >> Share

    
    December 2020
51. SPECHT L, Wong JYC, Filippi AR, Dabaja BS, et al
    In Reply to Scarpelli et al.
    Int J Radiat Oncol Biol Phys. 2020;108:1396.
    

    >> Share

    
    
52. SCARPELLI DB, Murphy B, Chang BH, Nemecek E, et al
    In Regard to Wong et al.
    Int J Radiat Oncol Biol Phys. 2020;108:1395-1396.
    

    >> Share

    
    November 2020
53. PATEL R, Zhang L, Desai A, Hoenerhoff MJ, et al
    Protons and High-Linear Energy Transfer Radiation Induce Genetically Similar Lymphomas With High Penetrance in a Mouse Model of the Aging Human Hematopoietic System.
    Int J Radiat Oncol Biol Phys. 2020;108:1091-1102.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share